Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety, and Acceptability of Internet-based Cognitive Behavioral Therapy Delivered Via Smartphone for Mild-to-moderate Major Depressive Disorder: a Multi-center, Double-blind, Randomized Controlled Trial

NCT05554289 is registered in ClinicalTrials.gov with Adai Technology (Beijing) Co., Ltd. as lead sponsor.

NCT NCT05554289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety, and Acceptability of Internet-based Cognitive Behavioral Therapy Delivered Via Smartphone for Mild-to-moderate Major Depressive Disorder: a Multi-center, Double-blind, Randomized Controlled Trial
Lead sponsor
Adai Technology (Beijing) Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
April 21, 2023
Completion date
October 25, 2024
Enrollment
315 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

depression